Skip to Content

Tranexamic acid intravenous formulations – Serious including fatal adverse reactions due to inadvertent intrathecal administration

11/12/2025
Medicines for human use Direct healthcare professional communication (DHPC)

Important Safety Information from Pfizer Healthcare Ireland Unlimited Company and Ibigen S.r.l. regarding Tranexamic acid intravenous formulations – Serious including fatal adverse reactions due to inadvertent intrathecal administration 

Documents

Opens in new window Tranexamic acid - Direct Healthcare Professional Communication PDF : 312KB | 11/12/2025